Selected article for: "long term and virus host"

Author: Baxter, Victoria K.; Heise, Mark T.
Title: Genetic control of alphavirus pathogenesis
  • Cord-id: 53d2vhy5
  • Document date: 2018_8_27
  • ID: 53d2vhy5
    Snippet: Alphaviruses, members of the positive-sense, single-stranded RNA virus family Togaviridae, represent a re-emerging public health concern worldwide as mosquito vectors expand into new geographic ranges. Members of the alphavirus genus tend to induce clinical disease characterized by rash, arthralgia, and arthritis (chikungunya virus, Ross River virus, and Semliki Forest virus) or encephalomyelitis (eastern equine encephalitis virus, western equine encephalitis virus, and Venezuelan equine encepha
    Document: Alphaviruses, members of the positive-sense, single-stranded RNA virus family Togaviridae, represent a re-emerging public health concern worldwide as mosquito vectors expand into new geographic ranges. Members of the alphavirus genus tend to induce clinical disease characterized by rash, arthralgia, and arthritis (chikungunya virus, Ross River virus, and Semliki Forest virus) or encephalomyelitis (eastern equine encephalitis virus, western equine encephalitis virus, and Venezuelan equine encephalitis virus), though some patients who recover from the initial acute illness may develop long-term sequelae, regardless of the specific infecting virus. Studies examining the natural disease course in humans and experimental infection in cell culture and animal models reveal that host genetics play a major role in influencing susceptibility to infection and severity of clinical disease. Genome-wide genetic screens, including loss of function screens, microarrays, RNA-sequencing, and candidate gene studies, have further elucidated the role host genetics play in the response to virus infection, with the immune response being found in particular to majorly influence the outcome. This review describes the current knowledge of the mechanisms by which host genetic factors influence alphavirus pathogenesis and discusses emerging technologies that are poised to increase our understanding of the complex interplay between viral and host genetics on disease susceptibility and clinical outcome.

    Search related documents:
    Co phrase search for related documents
    • acute infection and adaptive immune response innate: 1, 2, 3, 4, 5, 6, 7, 8
    • acute infection and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
    • acute infection and adaptor protein: 1, 2, 3
    • acute infection and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute infection and low frequency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute infection and low viremia: 1, 2, 3, 4, 5
    • acute infection and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute infection and lymphoid tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute infection and macrophage recruitment: 1, 2, 3, 4, 5
    • acute phase and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8
    • acute phase and adaptive immune response innate: 1
    • acute phase and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
    • acute phase and adhesion molecule: 1, 2
    • acute phase and low frequency: 1, 2
    • acute phase and low viremia: 1, 2
    • acute phase and lymph node: 1, 2, 3, 4, 5
    • acute phase and lymphocyte proliferation: 1
    • acute phase and lymphoid tissue: 1, 2
    • adaptive immune response and adhesion molecule: 1, 2, 3